Cargando…

Chondroitin Sulfate-Based Cryogels for Biomedical Applications

Cryogels attained from natural materials offer exceptional properties in applications such as tissue engineering. Moreover, Halloysite Nanotubes (HNT) at 1:0.5 weight ratio were embedded into CS cryogels to render additional biomedical properties. The hemolysis index of CS cryogel and CS:HNT cryogel...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirci, Sahin, Sahiner, Mehtap, Ari, Betul, Sunol, Aydin K., Sahiner, Nurettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406096/
https://www.ncbi.nlm.nih.gov/pubmed/34462411
http://dx.doi.org/10.3390/gels7030127
_version_ 1783746451752353792
author Demirci, Sahin
Sahiner, Mehtap
Ari, Betul
Sunol, Aydin K.
Sahiner, Nurettin
author_facet Demirci, Sahin
Sahiner, Mehtap
Ari, Betul
Sunol, Aydin K.
Sahiner, Nurettin
author_sort Demirci, Sahin
collection PubMed
description Cryogels attained from natural materials offer exceptional properties in applications such as tissue engineering. Moreover, Halloysite Nanotubes (HNT) at 1:0.5 weight ratio were embedded into CS cryogels to render additional biomedical properties. The hemolysis index of CS cryogel and CS:HNT cryogels was calculated as 0.77 ± 0.41 and 0.81 ± 0.24 and defined as non-hemolytic materials. However, the blood coagulation indices of CS cryogel and CS:HNT cryogels were determined as 76 ± 2% and 68 ± 3%, suggesting a mild blood clotting capability. The maximum% swelling capacity of CS cryogel was measured as 3587 ± 186%, 4014 ± 184%, and 3984 ± 113%, at pH 1.0, pH 7.4 and pH 9.0, respectively, which were reduced to 1961 ± 288%, 2816 ± 192, 2405 ± 73%, respectively, for CS:HNT cryogel. It was found that CS cryogels can hydrolytically be degraded 41 ± 1% (by wt) in 16-day incubation, whereas the CS:HNT cryogels degraded by 30 ± 1 wt %. There is no chelation for HNT and 67.5 ± 1% Cu(II) chelation for linear CS was measured. On the other hand, the CS cryogel and CS:HNT cryogel revealed Cu(II) chelating capabilities of 60.1 ± 12.5%, and 43.2 ± 17.5%, respectively, from 0.1 mg/mL Cu(II) ion stock solution. Additionally, at 0.5 mg/mL CS, CS:HNT, and HNT, the Fe(II) chelation capacity of 99.7 ± 0.6, 86.2 ± 4.7% and only 11.9 ± 4.5% were measured, respectively, while no Fe(II) was chelated by linear CS chelated Fe(II). As the adjustable and controllable swelling properties of cryogels are important parameters in biomedical applications, the swelling properties of CS cryogels, at different solution pHs, e.g., at the solution pHs of 1.0, 7.4 and 9.0, were measured as 3587 ± 186%, 4014 ± 184%, and 3984 ± 113%, respectively, and the maximum selling% values of CS:HNT cryogels were determined as 1961 ± 288%, 2816 ± 192, 2405 ± 73%, respectively, at the same conditions. Alpha glucosidase enzyme interactions were investigated and found that CS-based cryogels can stimulate this enzyme at any CS formulation.
format Online
Article
Text
id pubmed-8406096
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84060962021-09-01 Chondroitin Sulfate-Based Cryogels for Biomedical Applications Demirci, Sahin Sahiner, Mehtap Ari, Betul Sunol, Aydin K. Sahiner, Nurettin Gels Article Cryogels attained from natural materials offer exceptional properties in applications such as tissue engineering. Moreover, Halloysite Nanotubes (HNT) at 1:0.5 weight ratio were embedded into CS cryogels to render additional biomedical properties. The hemolysis index of CS cryogel and CS:HNT cryogels was calculated as 0.77 ± 0.41 and 0.81 ± 0.24 and defined as non-hemolytic materials. However, the blood coagulation indices of CS cryogel and CS:HNT cryogels were determined as 76 ± 2% and 68 ± 3%, suggesting a mild blood clotting capability. The maximum% swelling capacity of CS cryogel was measured as 3587 ± 186%, 4014 ± 184%, and 3984 ± 113%, at pH 1.0, pH 7.4 and pH 9.0, respectively, which were reduced to 1961 ± 288%, 2816 ± 192, 2405 ± 73%, respectively, for CS:HNT cryogel. It was found that CS cryogels can hydrolytically be degraded 41 ± 1% (by wt) in 16-day incubation, whereas the CS:HNT cryogels degraded by 30 ± 1 wt %. There is no chelation for HNT and 67.5 ± 1% Cu(II) chelation for linear CS was measured. On the other hand, the CS cryogel and CS:HNT cryogel revealed Cu(II) chelating capabilities of 60.1 ± 12.5%, and 43.2 ± 17.5%, respectively, from 0.1 mg/mL Cu(II) ion stock solution. Additionally, at 0.5 mg/mL CS, CS:HNT, and HNT, the Fe(II) chelation capacity of 99.7 ± 0.6, 86.2 ± 4.7% and only 11.9 ± 4.5% were measured, respectively, while no Fe(II) was chelated by linear CS chelated Fe(II). As the adjustable and controllable swelling properties of cryogels are important parameters in biomedical applications, the swelling properties of CS cryogels, at different solution pHs, e.g., at the solution pHs of 1.0, 7.4 and 9.0, were measured as 3587 ± 186%, 4014 ± 184%, and 3984 ± 113%, respectively, and the maximum selling% values of CS:HNT cryogels were determined as 1961 ± 288%, 2816 ± 192, 2405 ± 73%, respectively, at the same conditions. Alpha glucosidase enzyme interactions were investigated and found that CS-based cryogels can stimulate this enzyme at any CS formulation. MDPI 2021-08-26 /pmc/articles/PMC8406096/ /pubmed/34462411 http://dx.doi.org/10.3390/gels7030127 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Demirci, Sahin
Sahiner, Mehtap
Ari, Betul
Sunol, Aydin K.
Sahiner, Nurettin
Chondroitin Sulfate-Based Cryogels for Biomedical Applications
title Chondroitin Sulfate-Based Cryogels for Biomedical Applications
title_full Chondroitin Sulfate-Based Cryogels for Biomedical Applications
title_fullStr Chondroitin Sulfate-Based Cryogels for Biomedical Applications
title_full_unstemmed Chondroitin Sulfate-Based Cryogels for Biomedical Applications
title_short Chondroitin Sulfate-Based Cryogels for Biomedical Applications
title_sort chondroitin sulfate-based cryogels for biomedical applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406096/
https://www.ncbi.nlm.nih.gov/pubmed/34462411
http://dx.doi.org/10.3390/gels7030127
work_keys_str_mv AT demircisahin chondroitinsulfatebasedcryogelsforbiomedicalapplications
AT sahinermehtap chondroitinsulfatebasedcryogelsforbiomedicalapplications
AT aribetul chondroitinsulfatebasedcryogelsforbiomedicalapplications
AT sunolaydink chondroitinsulfatebasedcryogelsforbiomedicalapplications
AT sahinernurettin chondroitinsulfatebasedcryogelsforbiomedicalapplications